CLINICAL_TRIALS trial_result · 2022-02-10

Clinical Trial Update: Effect of Androgel on Type 2 Diabetic Males With Hypogonadism [Phase 4]

Phase 4 trial update on the effect of Androgel in type 2 diabetes mellitus patients with hypogonadism has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University at Buffalo | Conditions: Diabetes Mellitus Type 2 | Phase 4 | Status: COMPLETED | Results posted: 2022-02-10